Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies - PubMed (original) (raw)

Review

Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies

Bernd C Kieseier et al. Exp Neurol. 2007 Jan.

No abstract available

PubMed Disclaimer

Comment on

• Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions.
  Sättler MB, Demmer I, Williams SK, Maier K, Merkler D, Gadjanski I, Stadelmann C, Bähr M, Diem R. Sättler MB, et al. Exp Neurol. 2006 Sep;201(1):172-81. doi: 10.1016/j.expneurol.2006.04.015. Epub 2006 Jun 9. Exp Neurol. 2006. PMID: 16764858

Similar articles

• Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
  Biernacki K, Antel JP, Blain M, Narayanan S, Arnold DL, Prat A. Biernacki K, et al. Arch Neurol. 2005 Apr;62(4):563-8. doi: 10.1001/archneur.62.4.563. Arch Neurol. 2005. PMID: 15824253
• Translating new insights into treatment optimisation in multiple sclerosis.
  Fazekas F, Kieseier BC. Fazekas F, et al. J Neurol Sci. 2009 Feb 1;277 Suppl 1:S1-2. doi: 10.1016/S0022-510X(09)70002-4. J Neurol Sci. 2009. PMID: 19200857 No abstract available.
• Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis.
  Banwell B, Tremlett H. Banwell B, et al. Neurology. 2005 Mar 8;64(5):778-9. doi: 10.1212/01.WNL.0000153532.80277.21. Neurology. 2005. PMID: 15753408 No abstract available.
• Linkage between immunomodulation, neuroprotection and neurogenesis.
  Aharoni R, Arnon R. Aharoni R, et al. Drug News Perspect. 2009 Jul-Aug;22(6):301-12. doi: 10.1358/dnp.2009.22.6.1395253. Drug News Perspect. 2009. PMID: 19771319 Review.
• Approaches to neuroprotective strategies in multiple sclerosis.
  Tselis A, Khan OA, Lisak RP. Tselis A, et al. Expert Opin Pharmacother. 2010 Dec;11(17):2869-78. doi: 10.1517/14656566.2010.508070. Epub 2010 Aug 5. Expert Opin Pharmacother. 2010. PMID: 20687779 Review.

Cited by

• The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
  Rawji KS, Yong VW. Rawji KS, et al. Clin Dev Immunol. 2013;2013:948976. doi: 10.1155/2013/948976. Epub 2013 Jun 12. Clin Dev Immunol. 2013. PMID: 23840244 Free PMC article. Review.
• The innate immune response affects the development of the autoimmune response in Theiler's virus-induced demyelinating disease.
  Olson JK, Miller SD. Olson JK, et al. J Immunol. 2009 May 1;182(9):5712-22. doi: 10.4049/jimmunol.0801940. J Immunol. 2009. PMID: 19380818 Free PMC article.
• Clinical and experimental studies of multiple sclerosis in Russia: experience of the leading national research centers.
  Zavalishin IA, Belogurov AA Jr, Lomakin YA, Ponomarenko NA, Morozova SN, Suslina ZA, Piradov MA, Illarioshkin SN, Gabibov AG. Zavalishin IA, et al. Degener Neurol Neuromuscul Dis. 2015 Aug 6;5:83-90. doi: 10.2147/DNND.S46023. eCollection 2015. Degener Neurol Neuromuscul Dis. 2015. PMID: 32669915 Free PMC article.
• Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
  Kirn DH, Wang Y, Le Boeuf F, Bell J, Thorne SH. Kirn DH, et al. PLoS Med. 2007 Dec;4(12):e353. doi: 10.1371/journal.pmed.0040353. PLoS Med. 2007. PMID: 18162040 Free PMC article.
• Dendritic cells as therapeutic targets in neuroinflammation.
  Luessi F, Zipp F, Witsch E. Luessi F, et al. Cell Mol Life Sci. 2016 Jul;73(13):2425-50. doi: 10.1007/s00018-016-2170-9. Epub 2016 Mar 12. Cell Mol Life Sci. 2016. PMID: 26970979 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information